LUCELBA Trademark

Trademark Overview


On Tuesday, January 24, 2006, a trademark application was filed for LUCELBA with the United States Patent and Trademark Office. The USPTO has given the LUCELBA trademark a serial number of 78798191. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 14, 2013. This trademark is owned by Novartis AG. The LUCELBA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of and/or prevention of disorders of the nervous system, the immune system, the cardio-vascular system including diabetes and metabolic diseases, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations treating bacteria-based diseases; anti-infectives; anti-bacterials; antivirals; anti-biotics; anti-fungals; vaccines; diagnostic preparations for medical use
lucelba

General Information


Serial Number78798191
Word MarkLUCELBA
Filing DateTuesday, January 24, 2006
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 14, 2013
Registration Number3168729
Registration DateTuesday, November 7, 2006
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 22, 2006

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of and/or prevention of disorders of the nervous system, the immune system, the cardio-vascular system including diabetes and metabolic diseases, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; pharmaceutical preparations treating bacteria-based diseases; anti-infectives; anti-bacterials; antivirals; anti-biotics; anti-fungals; vaccines; diagnostic preparations for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 14, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Friday, June 14, 2013CANCELLED SEC. 8 (6-YR)
Thursday, June 25, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 7, 2006REGISTERED-PRINCIPAL REGISTER
Tuesday, August 22, 2006PUBLISHED FOR OPPOSITION
Wednesday, August 2, 2006NOTICE OF PUBLICATION
Sunday, July 2, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, July 2, 2006ASSIGNED TO LIE
Tuesday, June 6, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 6, 2006EXAMINER'S AMENDMENT ENTERED
Tuesday, June 6, 2006EXAMINERS AMENDMENT E-MAILED
Tuesday, June 6, 2006EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 6, 2006RESTORE TO TEAS PLUS
Tuesday, May 23, 2006NON-FINAL ACTION E-MAILED
Tuesday, May 23, 2006NON-FINAL ACTION WRITTEN
Tuesday, May 23, 2006REMOVED FROM TEAS PLUS
Tuesday, May 23, 2006ASSIGNED TO EXAMINER
Monday, January 30, 2006NEW APPLICATION ENTERED IN TRAM